ask="3.15"
ask_size="300"
average_daily_volume="3658870"
bid="2.90"
bid_size="1600"
book_value="-1.75"
change="+0.04"
change_from_200_day_moving_average="-1.58"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-5.92"
change_From_52_week_low="0.27"
change_in_percent="+1.47%"
close="3.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-0.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.58"
ex_dividend_date="N/A"
float_shares="113594000"
high="3.10"
high_52_weeks="9.02"
last_trade_date="3/3/2017"
last_trade_price="3.10"
last_trade_size="64809"
last_trade_time="4:00pm"
low="3.02"
low_52_weeks="2.83"
market_capitalization="401.81M"
moving_average_200_day="4.68"
moving_average_50_day="3.11"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.07"
pe_ratio="N/A"
peg_ratio="-1.21"
percent_change_from_200_day_moving_average="-33.73%"
percent_change_from_50_day_moving_average="-0.43%"
percent_change_from_52_week_high="-65.61%"
percent_change_from_52_week_low="+9.54%"
previous_close="3.06"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.79"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="4.68"
stock_exchange="NGM"
symbol="MACK"
volume="1622927"
weeks_range_52="2.83 - 9.02"
